+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors



Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors



European Journal of Cardio-Thoracic Surgery 37(1): 7-12



While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy. A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken. There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p=0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p=0.003), age <40 years (p=0.022) and the presence of thymic hyperplasia (p=0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p=0.91, 95% confidence interval (CI)=0.27-3.21) were not statistically relevant to better remission rate. VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056577226

Download citation: RISBibTeXText

PMID: 19615918

DOI: 10.1016/j.ejcts.2009.05.027


Related references

Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis. Interactive Cardiovascular and Thoracic Surgery 18(4): 475-481, 2014

Comparison of thymectomy with conservative treatment in autoimmune non-thymomatous myasthenia gravis. 2007

Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969. American Journal of Medicine 50(4): 465-474, 1971

Perioperative and long-term outcome of thymectomy for myasthenia gravis: comparison of surgical approaches and prognostic analysis. Chinese Medical Journal 126(1): 34-40, 2013

Comparative study for surgical management of thymectomy for non-thymomatous myasthenia gravis from the French national database EPITHOR. European Journal of Cardio-Thoracic Surgery 50(3): 418-422, 2016

Robotic-assisted thymectomy with Da Vinci II versus sternotomy in the surgical treatment of non-thymomatous myasthenia gravis: early results. Revue Neurologique 169(1): 30-36, 2013

Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database of Systematic Reviews 2013(10): Cd008111, 2013

Is thymectomy in non-thymomatous myasthenia gravis of any benefit?. Interactive Cardiovascular and Thoracic Surgery 18(3): 381-389, 2014

Mid-, and long-term effects of video-assisted thoracoscopic and transsternal thymectomy in treatment of non-thymomatous myasthenia gravis: analysis of 204 cases. Zhonghua Yi Xue Za Zhi 87(45): 3171-3173, 2007

Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review. Journal of Huazhong University of Science and Technology. Medical Sciences 34(6): 942-949, 2014

Long-term outcome after thymectomy for myasthenia gravis and analysis of prognostic factors. Fudan Xuebao 33(6): 785-788,793, 2006

Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy in non-thymomatous myasthenia gravis patients. Journal of the Neurological Sciences 217(2): 233, 2004

Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: Remission after 6 years of follow-up. Journal of the Neurological Sciences 212(1-2): 31-36, 2003

Indications, efficacies and periopertive problems of thymectomy in non-thymomatous myasthenia gravis. Rinsho Shinkeigaku 47(11): 872-874, 2007